(Q42953743)

11 November 2017

title

Population-based risk factors and resource utilization for HCC: US perspective (English)

1 reference

11 November 2017

main subject

hepatocellular carcinoma

1 reference

A. Sanyal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20666689

12 June 2024

A. Poklepovic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20666689

12 June 2024

E. Moyneur

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20666689

12 June 2024

V. Barghout

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20666689

12 June 2024

language of work or name

English

0 references

publication date

1 September 2010

1 reference

full work available at URL

11 November 2017

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2010.506375

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

Current Medical Research and Opinion

12 June 2024

published in

1 reference

11 November 2017

volume

26

1 reference

11 November 2017

issue

9

1 reference

11 November 2017

page(s)

2183-2191

1 reference

Management of hepatocellular carcinoma

11 November 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization

12 June 2024

3

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

Sorafenib in advanced hepatocellular carcinoma

12 June 2024

4

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

Epidemiology of hepatocellular carcinoma in USA

12 June 2024

5

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

12 June 2024

6

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis

12 June 2024

9

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study

12 June 2024

10

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis

12 June 2024

11

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival

12 June 2024

12

1 reference

https://api.crossref.org/works/10.1185/03007995.2010.506375

12 June 2024

Identifiers

1 reference

release_ovif5bohlffb7pxlbv5mwjibl4

11 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ovif5bohlffb7pxlbv5mwjibl4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference